ThinkSabio

$IOVA

$13.46▲ -9.2% YTD

13 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History
News
IOVA ▼ -9.2% - Iovance Biotherapeutics, Inc.
CP $13.46▲ -9.2%Oct 29, 2026 · ThinkSabio Blog

$IOVA - Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)…

News
IOVA ▲ +13.2% - Iovance Biotherapeutics, Inc.
CP $16.50▲ +13.2%Oct 28, 2026 · ThinkSabio Blog

$IOVA - Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precisi…

News
IOVA ▲ +0.1% - Iovance Biotherapeutics, Inc.
CP $13.77▲ +0.1%Oct 27, 2026 · ThinkSabio Blog

$IOVA - Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026…

News
IOVA ▲ +2.0% - Iovance Biotherapeutics, Inc.
CP $14.36▲ +2.0%Oct 26, 2026 · ThinkSabio Blog

$IOVA - Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026…

News
IOVA ▼ -2.6% - Iovance Biotherapeutics, Inc.
CP $13.79▲ -2.6%Oct 23, 2026 · ThinkSabio Blog

$IOVA - Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline…

News
IOVA ▼ -0.7% - Iovance Biotherapeutics, Inc.
CP $13.55▲ -0.7%Oct 19, 2026 · ThinkSabio Blog

$IOVA - Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026…

News
IOVA ▲ +0.2% - Iovance Biotherapeutics, Inc.
CP $14.83▲ +0.2%Oct 1, 2026 · ThinkSabio Blog

$IOVA - Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer…

News
IOVA ▲ +0.3% - Iovance Biotherapeutics, Inc.
CP $14.49▲ +0.3%Sep 30, 2026 · ThinkSabio Blog

$IOVA PT raised to $18 at Wells Fargo…

News
IOVA ▲ +3.7% - Iovance Biotherapeutics, Inc.
CP $11.40▲ +3.7%Sep 29, 2026 · ThinkSabio Blog

$IOVA - Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million…

News
IOVA ▲ +2.3% - Iovance Biotherapeutics, Inc.
CP $10.26▲ +2.3%Sep 18, 2026 · ThinkSabio Blog

$IOVA - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)…

News
IOVA ▲ +1.1% - Iovance Biotherapeutics, Inc.
CP $8.80▲ +1.1%Sep 4, 2026 · ThinkSabio Blog

$IOVA - Iovance Biotherapeutics to Present at Upcoming Conferences…

SEC 13D/G
IOVA - Iovance Biotherapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified
$6.13▲ 143.25%Aug 7, 2026 · ThinkSabio Blog

$IOVA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #IOVA Iovance Biotherapeutics, Inc. : $6.13 Sector: Healthcare |…

SEC 13D/G
$IOVA SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks Simplified
$4.72▲ 87.30%Jul 28, 2026 · ThinkSabio Blog

$IOVA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #IOVA : $4.72 Sector: Healthcare | YTD: 🔼+ 87.30% The SEC disclo…